Singh Sahib, Facciorusso Antonio, Vinayek Rakesh, Dutta Sudhir, Dahiya Dushyant Singh, Aswath Ganesh, Sharma Neil, Inamdar Sumant
Department of Internal Medicine, Sinai Hospital of Baltimore, Baltimore, MD 21215, USA.
Gastroenterology Unit, Department of Medical and Surgical Sciences, University of Foggia, 71122 Foggia, Italy.
Cancers (Basel). 2024 Dec 30;17(1):89. doi: 10.3390/cancers17010089.
Pancreatic cancer is associated with high rates of morbidity and mortality. Endoscopic ultrasound (EUS)-guided biopsy has become the standard diagnostic modality per the guidelines. The use of EUS has been growing for providing various treatments in patients with pancreatic cancers: biliary and gallbladder drainage for those with malignant biliary obstruction, gastroenterostomy for malignant gastric outlet obstruction, celiac plexus/ganglia neurolysis for pain control, radiofrequency ablation, placement of fiducial markers, and injection of local chemotherapeutic agents. In this review, we explore the recent clinical studies evaluating the EUS-guided treatments in pancreatic cancer.
胰腺癌与高发病率和高死亡率相关。根据指南，内镜超声（EUS）引导下活检已成为标准诊断方式。EUS在为胰腺癌患者提供各种治疗方面的应用不断增加：为恶性胆管梗阻患者进行胆管和胆囊引流，为恶性胃出口梗阻患者进行胃肠吻合术，为控制疼痛进行腹腔神经丛/神经节松解术，射频消融，放置基准标记物以及注射局部化疗药物。在本综述中，我们探讨了评估EUS引导下胰腺癌治疗的近期临床研究。
